Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase is a large, multi-subunit enzyme complex found in the inner mitochondrial membrane of eukaryotes and in the plasma membrane of prokaryotes. It is also present in the thylakoid membrane of chloroplasts. Its primary function is to catalyze the synthesis of adenosine triphosphate (ATP) from adenosine diphosphate (ADP) and inorganic phosphate (Pi), utilizing energy derived from a transmembrane proton gradient. It can also hydrolyze ATP to pump protons against their gradient. Mutations affecting various structural genes can impair assembly/function leading to mitochondrial diseases due to insufficient cellular energy production. Over 250 natural/synthetic inhibitors have been identified; these target different parts/subunits for research purposes or potential therapeutic applications—including antimicrobial agents or anti-cancer strategies by disrupting tumor cell metabolism.
Inhibition of ATP synthesis or ATP hydrolysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP Synthase (N/A).